Author

B. King-Kallimanis

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Will AI widen the gap? Exploring lung cancer patient perceptions of AI.

400 Background: Artificial intelligence (AI) is being integrated throughout the cancer care continuum, from administrative functions to diagnostic and monitoring processes, yet substantial concerns regarding implementation and quality remain. One important concern is that it will exacerbate inequities already p...

C. Ducille, K. Glynn, U. B. Basu Roy et al. · JCO Oncology Practice · 0 citations

Review Open access Sep 2026

PRO‑CTCAE in Oncology Drug Evaluation: Cross-Agency Review of Regulatory and Health Technology Assessment Decision-Making in the United States and Europe.

Harmonized, cross-agency guidance on PRO-CTCAE item selection, endpoint definition, analysis, and presentation may help support its consistent and meaningful use in future oncology submissions and regulatory and HTA decision-making.

E. Basch, Matthew Reaney, J. Roydhouse et al. · Journal of the National Canc... · 0 citations